Try our Advanced Search for more refined results
October 17, 2018
Anacor Pharmaceuticals, Inc. v. Lupin Limited et al
Case Number:
1:18-cv-01606
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 27, 2021
FlatWing Won't Get $690K Atty Fees In Pfizer Unit Patent Fight
A Delaware federal judge on Monday denied a bid by two firms representing FlatWing Pharmaceuticals LLC to have Pfizer unit Anacor Pharmaceuticals Inc. reimburse roughly $690,000 in attorney fees that FlatWing incurred in patent litigation.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login